KRAS and neoplasm: In KRAS-mutant lung cancer, senescent macrophages secrete CCL2 to recruit MDSCs, while IL-10 and TGF-β polarize tumor-associated macrophages (TAMs) toward an immunosuppressive M2 phenotype, crippling cytotoxic T cell activity (74).